Trial access to BioFinder: available through December 2025 

The Ottenheimer Library has trial access to BioFinder on the CAS SciFinder-n platform through Dec. 31, 2025. BioFinder provides tools and data on bioactivity, chemical structures, biological pathways, disease-associated biomarkers, antibodies and ADCs, and immunotherapies. It also offers predictive models for ligand screening, interactive 3D visualizations for exploring biologically relevant compounds, and drug intelligence information such as clinical trial status, indications and targets.

If BioFinder sounds useful for your research or coursework, you can access the resource here and share your feedback here.

For questions, contact Bonnie Bennet at [email protected].